Recently, the FDA issued a statement concerning the agency’s efforts “to protect women’s health and enhance safety information available to patients considering breast implants.” As an advocate for women’s health and empowerment, I urge women to engage in conversations with their physicians concerning implant safety, so I’m particularly pleased that the FDA recommends that breast […]
Read More
Textured Breast Implants and BIA-ALCL A number of reports have recently hit the news circuit regarding the safety of breast implants and an increasing number of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) cases. With an initial 64 incidences, the FDA first identified the connection between breast implants and BIA-ALCL in 2011. The FDA has […]
Read More
